Nurix Therapeutics, Inc. NRIX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s quick ratio?
- Nurix Therapeutics, Inc. (NRIX) reported quick ratio of 6× in Q4 2025.
- How has Nurix Therapeutics, Inc.'s quick ratio changed year-over-year?
- Nurix Therapeutics, Inc.'s quick ratio decreased by 4.0% year-over-year, from 6.3× to 6×.
- What is the long-term trend for Nurix Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s quick ratio has grown at a 0.9% compound annual growth rate (CAGR), from 6.7× to 7×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.